<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:411e0d0e-6ecc-4465-b060-bbd66d737eb5,g:60eda74f-8087-436a-bd9b-613747bc57ce,d:74c362ca5a804506855d08b0131f5bde--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>anab-20210617</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV80L2ZyYWc6ZTJkM2FiNWI5MWIxNGY2MGJmNTY1OTYxYmIwYThhODMvdGFibGU6NjU2ZmM0MGZkMWU5NGNkMDkwNDJhMTNkMDg2ZTg3M2MvdGFibGVyYW5nZTo2NTZmYzQwZmQxZTk0Y2QwOTA0MmExM2QwODZlODczY18yLTEtMS0xLTA_31d6e3e7-6fd9-4563-b4a8-42bddaf1f5de">0001370053</ix:nonNumeric><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV80L2ZyYWc6ZTJkM2FiNWI5MWIxNGY2MGJmNTY1OTYxYmIwYThhODMvdGFibGU6NjU2ZmM0MGZkMWU5NGNkMDkwNDJhMTNkMDg2ZTg3M2MvdGFibGVyYW5nZTo2NTZmYzQwZmQxZTk0Y2QwOTA0MmExM2QwODZlODczY181LTEtMS0xLTA_25e0d13a-78e4-4e38-b700-6b9d065e8932">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="anab-20210617.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i14128383f3b3421b90d87a83d968927c_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001370053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i74c362ca5a804506855d08b0131f5bde_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xODE1_f361a7a2-c136-4742-83c0-8fdba5e1a6ec">8-K</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT PURSUANT TO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date of Report: <ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xOTE_14dc2df3-d4b3-441b-8d5d-c558b61af05c">June 17, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Date of earliest event reported)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xNzk5_24bdfb4d-6b02-45e6-9f71-98889b7e84fd">ANAPTYSBIO, INC</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.857%"><tr><td style="width:1.0%"></td><td style="width:33.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGFibGU6NzJjMjA2YmI1OWZmNGJlNWJlMzRkZjU2ZmQzM2RlNWMvdGFibGVyYW5nZTo3MmMyMDZiYjU5ZmY0YmU1YmUzNGRmNTZmZDMzZGU1Y18wLTAtMS0xLTA_f7600af1-36f5-4364-8bcc-754daca272d8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGFibGU6NzJjMjA2YmI1OWZmNGJlNWJlMzRkZjU2ZmQzM2RlNWMvdGFibGVyYW5nZTo3MmMyMDZiYjU5ZmY0YmU1YmUzNGRmNTZmZDMzZGU1Y18wLTEtMS0xLTA_586af800-408b-4b2c-a8ae-52d13d892887">001-37985</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGFibGU6NzJjMjA2YmI1OWZmNGJlNWJlMzRkZjU2ZmQzM2RlNWMvdGFibGVyYW5nZTo3MmMyMDZiYjU5ZmY0YmU1YmUzNGRmNTZmZDMzZGU1Y18wLTItMS0xLTA_227ff4bc-7c8b-4779-8ee8-dc74e977a591">20-3828755</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xODA4_a31a14bf-b9c2-40ed-a607-83814d5e1679">10770 Wateridge Circle</ix:nonNumeric>, <ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xODAw_98ddd545-0d9c-4ff0-83a7-4a306af46ac1">Suite 210,</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xODA0_8234ed58-7028-46e5-a7de-f972385aadb0">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xODE2_e968aae8-48bd-4e77-9e3f-5af32baa946f">CA</ix:nonNumeric>  <ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xODA1_005707ff-445b-483d-a55b-44e70d3b7f66">92121</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices, and Zip Code)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xODEw_5578570b-80af-4169-9da2-0a15f463916b">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xODAx_1715d46b-0519-466f-af43-e7933be8595c">362-6295</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xODEz_fc2fe930-1215-49d4-a917-b9b1738e41fb">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communication pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xNzk2_35e4c7c8-e59a-4b90-bc20-b53a1139071f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xNzk3_6d3f32bc-b46d-4719-934b-a2b9fbccc267">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communication pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xNzk4_7d522f12-8e11-4e85-a883-a7ba1ca36244">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communication pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.866%"><tr><td style="width:1.0%"></td><td style="width:35.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGFibGU6YThhMmQzYWE3YjQzNDczYmI4NGQ5NjIyM2Y1NmRiY2IvdGFibGVyYW5nZTphOGEyZDNhYTdiNDM0NzNiYjg0ZDk2MjIzZjU2ZGJjYl8xLTAtMS0xLTA_e443deee-cfae-4e6b-b82b-80329fcb5d9d">Common Stock, par value $0.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGFibGU6YThhMmQzYWE3YjQzNDczYmI4NGQ5NjIyM2Y1NmRiY2IvdGFibGVyYW5nZTphOGEyZDNhYTdiNDM0NzNiYjg0ZDk2MjIzZjU2ZGJjYl8xLTEtMS0xLTA_ac8fd484-7623-4a9e-9606-8bae5327cd7f">ANAB</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGFibGU6YThhMmQzYWE3YjQzNDczYmI4NGQ5NjIyM2Y1NmRiY2IvdGFibGVyYW5nZTphOGEyZDNhYTdiNDM0NzNiYjg0ZDk2MjIzZjU2ZGJjYl8xLTItMS0xLTA_0ecf2ed2-b3a7-4d46-b175-f3167709b443">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i14128383f3b3421b90d87a83d968927c_D20210617-20210617" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjc0YzM2MmNhNWE4MDQ1MDY4NTVkMDhiMDEzMWY1YmRlL3NlYzo3NGMzNjJjYTVhODA0NTA2ODU1ZDA4YjAxMzFmNWJkZV8xL2ZyYWc6NzE1NzQ2YzJmYjllNGYzOGEzNWQ3OTUwZDA0ZDE0MzgvdGV4dHJlZ2lvbjo3MTU3NDZjMmZiOWU0ZjM4YTM1ZDc5NTBkMDRkMTQzOF8xODA5_cb92e8c8-a050-4805-97ca-111e29a6a930">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i74c362ca5a804506855d08b0131f5bde_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:5pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Item&#160;5.07.&#160;&#160;&#160;&#160;Submission of Matters to a Vote of Security Holders.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On June 17, 2021, AnaptysBio, Inc. (the &#8220;Company&#8221;) held its 2021 Annual Meeting of Stockholders and the following proposals were adopted: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Election of three Class I directors, Dennis Fenton, Ph.D., James Topper, M.D., Ph.D., and Oleg Nodelman, each to serve a three-year term, which will expire at the 2024 Annual Meeting of Stockholders or until such time as his respective successor have been duly elected and qualified or until such director's earlier resignation or removal:</span></div><div><span><br/></span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.942%"><tr><td style="width:1.0%"></td><td style="width:31.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nominees</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Withheld/Abstaining</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dennis Fenton, Ph.D.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,114,189</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,677,584</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879,451</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">James Topper, M.D., Ph.D.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,036,482</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,755,291</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879,451</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Oleg Nodelman</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,772,618</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,155</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879,451</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Ratification of the appointment of KPMG LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2021:</span></div><div><span><br/></span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.942%"><tr><td style="width:1.0%"></td><td style="width:31.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Withheld/Abstaining</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,645,851</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,613</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,761</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Non-binding, advisory approval of compensation paid to the Company&#8217;s named executive officers: </span></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.942%"><tr><td style="width:1.0%"></td><td style="width:31.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Withheld/Abstaining</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,696,275</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,221</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,277</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879,451</span></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">SIGNATURES</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AnaptysBio, Inc.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date:  June 17, 2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">/s/Eric Loumeau</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Name: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Eric Loumeau</span></div></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Title: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Chief Operating Officer and General Counsel</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "anab-20210617.htm", "description": "8-K", "secsgml_size_bytes": 42305}]
{"company-data": {"conformed-name": "ANAPTYSBIO, INC", "cik": "0001370053", "assigned-sic": "2834", "irs-number": "203828755", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-37985", "film-number": "211025643"}, "business-address": {"street1": "10770 WATERIDGE CIRCLE, SUITE 210", "city": "SAN DIEGO", "state": "CA", "zip": "92121", "phone": "858-362-6295"}, "mail-address": {"street1": "10770 WATERIDGE CIRCLE, SUITE 210", "city": "SAN DIEGO", "state": "CA", "zip": "92121"}, "former-company": [{"former-conformed-name": "ANAPTYSBIO INC", "date-changed": "20080828"}, {"former-conformed-name": "ANAPTYS BIOSCIENCES INC", "date-changed": "20060724"}]}
anab-20210617
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report:
June 17, 2021
(Date of earliest event reported)
ANAPTYSBIO, INC
.
(Exact Name of Registrant as Specified in Charter)
Delaware
001-37985
20-3828755
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
10770 Wateridge Circle
,
Suite 210,
San Diego
,
CA
92121
(Address of Principal Executive Offices, and Zip Code)
(
858
)
362-6295
(Registrant's Telephone Number, Including Area Code)
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
ANAB
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
(17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.07.    Submission of Matters to a Vote of Security Holders.
On June 17, 2021, AnaptysBio, Inc. (the "Company") held its 2021 Annual Meeting of Stockholders and the following proposals were adopted:
1.
Election of three Class I directors, Dennis Fenton, Ph.D., James Topper, M.D., Ph.D., and Oleg Nodelman, each to serve a three-year term, which will expire at the 2024 Annual Meeting of Stockholders or until such time as his respective successor have been duly elected and qualified or until such director's earlier resignation or removal:
Nominees
Shares For
Shares Withheld/Abstaining
Broker Non-Votes
Dennis Fenton, Ph.D.
18,114,189
2,677,584
2,879,451
James Topper, M.D., Ph.D.
18,036,482
2,755,291
2,879,451
Oleg Nodelman
20,772,618
19,155
2,879,451
2.
Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021:
Shares For
Shares Against
Shares Withheld/Abstaining
Broker Non-Votes
23,645,851
14,613
10,761
0
3.
Non-binding, advisory approval of compensation paid to the Company's named executive officers:
Shares For
Shares Against
Shares Withheld/Abstaining
Broker Non-Votes
20,696,275
91,221
4,277
2,879,451
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
AnaptysBio, Inc.
Date:  June 17, 2021
By:
/s/Eric Loumeau
Name:
Eric Loumeau
Title:
Chief Operating Officer and General Counsel